Association of polymorphisms in the 3′UTR of ErbB2 with the risk of hepatocellular carcinoma

被引:0
|
作者
Fan, Ye [1 ]
Zhang, Chuanyong [1 ]
Qian, Xiaofeng [1 ]
机构
[1] Nanjing Med Univ, Affiliated Hosp 1, Liver Transplantat Ctr, 300 Guangzhou Rd, Nanjing, Jiangsu, Peoples R China
关键词
SNP; ErbB2; HCC; miRNA; GROWTH-FACTOR RECEPTOR; C-ERBB-2; PROTEIN; CANCER; ADENOCARCINOMA; EXPRESSION; MICRORNA;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
ErbB2 can act as an oncogene and its related signaling server as essential roles in tumorigenesis. Polymorphisms in ErbB2 have been reported related to bad prognosis of with human cancer, however the association between SNP in 3'UTR of ErbB2 so far. In this study rs113054794 and rs76322625 located in the 3'UTR of ErbB2 was selected to evaluate its relationship with the risk of HCC among Chinese population. In this study, SNP of rs113054794 in the 3'-UTR of ErbB2 was involved as a risk factor in the occurrence of HCC. SNP rs113054794 could be regulated by miR-221-5p which caused an up-regulation of ErbB2 in patients. Furthermore, the carriers of CA and AA genotype in rs113054794 presented poor differentiation, a big tumor size as well as the high probability of metastasis. In conclusion, our findings have shown that the SNP rs113054794 in ErbB2 3'-UTR, through disrupting the regulatory role of miR-221-5p in ErbB2 expression, which might act as a promotion factor in the pathogenesis of HCC.
引用
收藏
页码:3521 / 3528
页数:8
相关论文
共 50 条
  • [1] Association of CAA and TATC Insertion/Deletion Genetic Polymorphisms in RTN4 3'-UTR with Hepatocellular Carcinoma Risk
    Wang, NaNa
    Chen, KeYu
    Xu, Jia
    Yuan, Fang
    Li, HongYu
    Deng, FengMei
    Zhang, LuShun
    PATHOLOGY & ONCOLOGY RESEARCH, 2018, 24 (01) : 31 - 34
  • [2] Association Between ERBB2 and ERBB3 Polymorphisms and Dyslipidaemia and Serum Lipid Levels in a Chinese Population
    Zhu, Lijun
    Fang, Zhengmei
    Huang, Mengyun
    He, Lianping
    Xu, Miao
    Yu, Yue
    Jin, Yuelong
    Chen, Yan
    Yao, Yingshui
    BIOCHEMICAL GENETICS, 2025,
  • [3] A novel mutation in the tyrosine kinase domain of ERBB2 in hepatocellular carcinoma
    Bekaii-Saab, Tanios
    Williams, Nita
    Plass, Christoph
    Calero, Miguel Villalona
    Eng, Charis
    BMC CANCER, 2006, 6 (1)
  • [4] A novel mutation in the tyrosine kinase domain of ERBB2 in hepatocellular carcinoma
    Tanios Bekaii-Saab
    Nita Williams
    Christoph Plass
    Miguel Villalona Calero
    Charis Eng
    BMC Cancer, 6
  • [5] ERBB2 mutations and association with molecular phenotype in urothelial carcinoma
    Machaalani, Marc
    El Zarif, Talal
    Stockhammer, Paul
    Semaan, Karl
    Eid, Marc
    Chehade, Razane El Hajj
    Nawfal, Rashad
    Yekeduz, Emre
    Nassar, Amin
    Lee, Gwo-Shu Mary
    Baca, Sylvan C.
    Choueiri, Toni K.
    Grant, Michael J.
    Bellmunt, Joaquim
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] Association analysis of ERBB2 amplicon genetic, polymorphisms and STARD3 expression with risk of gastric cancer in the Chinese population
    Qiu, Yue
    Zhang, Zuo-Yang
    Du, Wei-Dong
    Ye, Lei
    Xu, Song
    Zuo, Xian-Bo
    Zhou, Fu-Sheng
    Chen, Gang
    Ma, Xue-Ling
    Schneider, Marion E.
    Xia, Hong-Zhen
    Zhou, Yuan
    Wu, Ji-Feng
    Yuan-Hong, Xu
    Zhang, Xue-Jun
    GENE, 2014, 535 (02) : 225 - 232
  • [7] No Association Between the Haplotypic Block in the 3′ UTR of GRP78 and Risk of Hepatocellular Carcinoma
    Zhu, Xiao
    Wang, Jinlong
    Wang, Qian
    Zhang, Ying
    Chen, Lianzhou
    Tian, Linwei
    Shen, Hongzhuo
    Lin, Marie C. M.
    Wang, Min
    Xie, Dan
    Kung, Hsiangfu
    HEPATO-GASTROENTEROLOGY, 2010, 57 (102-03) : 1191 - 1195
  • [8] ASSOCIATION OF GENETIC POLYMORPHISMS OF MICRORNA WITH RISK OF HEPATOCELLULAR CARCINOMA
    Hwang, Seong Gyu
    Kim, Wonhee
    Rim, Kyu Sung
    Lee, Jung Min
    Hong, Sung Pyo
    Park, Pil Won
    Ko, Kwang Hyun
    Kwon, Chang-Il
    Kwon, Sung Won
    Kim, Kook-Hyun
    HEPATOLOGY, 2010, 52 (04) : 1189A - 1190A
  • [9] Lack of somatic ErbB2 tyrosine kinase domain mutations in hepatocellular carcinoma
    Wong, Chiung-Ing
    Yap, Hui-Ling
    Lim, Seng-Gee
    Guo, Jia-Yi
    Goh, Boon-Cher
    Lee, Soo-Chin
    HEPATOLOGY RESEARCH, 2008, 38 (08) : 838 - 841
  • [10] EGFR/ERBB2 Amplifications and Alterations Associated With Resistance to Lenvatinib in Hepatocellular Carcinoma
    Lim, Mir
    Franses, Joseph W.
    Imperial, Robin
    Majeed, Umair
    Tsai, Jill
    Hsiehchen, David
    GASTROENTEROLOGY, 2023, 164 (06) : 1006 - +